Table 6 contains the results of an analysis of correlations between enzymatic activity and susceptibility to antifungal drugs of Candida krusei
isolated from hand surfaces.
Sterol content and polyene antibiotic resistance in isolates of Candida krusei
, Candida parakrusei, and Candida tropicalis.
Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei
, Candida inconspicua, and Candida norvegensis strains.
After amplification, species was identified on 2% agarose gel along with 1kb DNA ladder (Generular), amplicons of size 510 base-pair (bp) were identified as Candida krusei
, 520 bp as Candida parapsilosis, 524 bp as Candida tropicalis, 535 bp as Candida albicans and 871 bp as Candida glabrata Gender-wise distribution of Candida species was observed according to which more females 144(65.
Las cepas control positivo para la prueba de actividad fosfolipasa fueron Candida albicans ATCC 90028, Candida krusei
ATCC 6258 y Candida parapsilosis ATCC 22019.
Biofire Blood Culture ID Panel--can simultaneously detect Enterococcus species, Listeria monocytogenes, Staphylococcus species, Staphylococcus aureus, Streptococcus species, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Acinetobacter baumannii, Haemophilus influenza, Neisseria meningib'des, Psuedomonas aeruginosa, Enterobacteriaceae species, Enterobacter cloacae complex, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus species, Serratia marcescens, Candida albicans, Candida glabrate, Candida krusei
, Candida parapsilosis, and Candida tropicalis.
2013) other yeast used was identified as Candida krusei
as the biodetheobrominator.
The standard strain Candida parapsilosis (American Type Culture Collection [ATCC] 22019), Candida krusei
(ATCC 6258), and C.
3 shows out of 124 isolates isolated Candida albicans were 43%, Candida tropicals were 42%, Candida krusei
were 6%, Candida guilliermondii were 4%, Candida inconspicua, Candida parapsilosis, Candidad glabrata, Candida glabrata, Candida rugosa and Candida lusitaniae were 1% each.
The strains used were Candida albicans ATCC 14053, Candida albicans ATCC 64548 and Candida krusei
isolates were the least in number for expressing any of the virulence factors.
The antibacterial activity was tested against clinical strains of Escherichia coli, Klebsiella pneumonia, Pseudomonas aeroginosa and Staphylococcus aureus using Mueller Hinton broth and the antifungal activity against Candida albicans, Candida krusei
, Candida tropicalis and Candida guilliermondii with RPMI 1640 as test medium.